The use of abdominal binders to treat over-shunting headaches

Frederick H Sklar1, Laszlo Nagy, Brian D Robertson

  • 1Department of Pediatric Neurosurgery, Children’s Medical Center Dallas, TX 75235, USA. fsklar@nsfc.us

Insights

Abdominal binders effectively treat headaches in children with over-shunting, offering a noninvasive option before surgery. This therapy provided significant relief for most patients, with benefits often persisting after discontinuation.

Area of Science:

  • Pediatric Neurosurgery
  • Hydrocephalus Management
  • Cerebrospinal Fluid Dynamics

Background:

  • Headaches are a frequent complication in pediatric patients with shunts.
  • Over-shunting can cause intermittent headaches, often worsening when lying down.
  • Identifying and managing over-shunting headaches is crucial for patient well-being.

Purpose of the Study:

  • To evaluate the efficacy of abdominal binders in treating headaches associated with over-shunting in children.
  • To determine if abdominal binders represent a viable noninvasive therapeutic option.

Main Methods:

  • Retrospective chart review of 483 pediatric patients with shunts over an 18-year period.
  • Identification of patients diagnosed with over-shunting headaches.
  • Analysis of treatment outcomes for 70 patients managed with abdominal binders.

Main Results:

  • Over half of the reviewed patients (53.4%) experienced headaches.
  • A diagnosis of over-shunting was made in 21.3% of all patients.
  • 85.8% of patients treated with abdominal binders showed significant headache improvement, with relief often persisting after binder removal.

Conclusions:

  • Abdominal binders offer an effective, noninvasive treatment for over-shunting headaches in pediatric populations.
  • This therapy should be considered prior to surgical interventions.
  • The binder may influence intracranial pulse pressures, potentially impacting cerebrovascular interactions for sustained relief.
Abstract

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...